抗体类型IgG1 免疫原Affinity purified chicken heart A-CAM. 实际分子量140KD 成分200μg/mL antibody with PBS,0.02% NaN3,1mg BSA 纯化方式Ascites 浓度200μg/mL 产品形态溶液 保存条件12 months from date of receipt,-20℃ as supplied.6 months 2 to 8℃ after reconstitution.Avoid repeated freezing ...
克隆性:多克隆抗体 用途:WB,FC, IHC,ICC, IF 交叉反应性:人,小鼠 分子量:140KDa 推荐稀释比例:WB(1:500-1:1000),IF(1:200),IHC(1:200),ICC(1:200),FC(1:50) About this Antibody Name N-Cadherin Rabbit Polyclonal Antibody Category
指标别名Cadherin 2;CD325;CDH2;CDHN;CDw325;N cadherin;NCAD;N-cadherin;Neural cadherin 克隆性Polyclonal 检验物种human,mouse,rat 应用范围WB,ICC,IF,IHC,FCM 基因名称CDH2 抗体来源Rabbit 抗体类型IgG 计算分子量100kDa 成分Rabbit IgG,1mg/mL in PBS with 0.02% sodium azide,50% glycerol,pH7.2 ...
中文名称N-钙粘附分子抗体 别名Cadherin 2; Cadherin 2 N cadherin neuronal; Cadherin 2 type 1; Cadherin 2 type 1 N cadherin neuronal; cadherin 2 type 1 N-cadherin neuronal; Cadherin2; Calcium dependent adhesion protein neuronal; CD325; CD325 antigen; CDH2; CDHN; CDw325; CDw325 antigen; ...
N-钙粘蛋白由906个氨基酸组成(点击了解序列),理论分子量为99.8KDa。在S95和S135位点存在磷酸化修饰。据报道,N-钙粘蛋白在细胞质中高表达可以导致大量癌基因作用明显增强。艾美捷科技为您推荐Abbkine的CDH2/N-cadherin抗体:【IF,IHC, ELISA,WB】【人,小鼠,大鼠】均可使用! 产品名称及描述:N-cadherin Polyclonal ...
英文名称: Human N-cadherin (NCAD) ELISA Kit 实验类型: 双抗体夹心法 检测范围: 0.15-10ng/mL(特殊要求可定制) 灵敏度: 0.04ng/mL 种属: 人 保存温度: 2-8℃ 样本类型: 血清、血浆、组织匀浆、细胞裂解液、细胞培养上清 和 其他生物液体 产品说明书 ...
理论分子量140kDa 实际分子量140kDa 存储缓冲液Store at -20℃. Avoid freeze / thaw cycles. Buffer: PBS with 0.02% sodium azide,0.05% BSA,50% glycerol,pH7.3. 实验方法Western blotting 阳性样本HeLa,293T,NIH/3T3,C6 细胞定位 纯化方式Affinity purification ...
抗体形式 affinity isolated antibody antibody product type primary antibodies 克隆 polyclonal 形式 buffered aqueous solution 分子量 97 99 species reactivity mouse, rat 浓度 5.26 mg/ml technique(s) immunofluorescence: 1:50-1:200immunohistochemistry: 1:50-1:200western blot: 1:500-1:2000 UniProt登记号...
Biomatik是生物试剂一站式购物中心,提供29000+ELISA试剂盒,27000+抗体,17000+重组蛋白,280+生物试剂。 应用类型 Western blotting: 0.5-2ug/mL;Immunohistochemistry: 5-20ug/mL;Immunocytochemistry: 5-20ug/mL;Optimal working dilutions must be determined by end user. ...